MTOR and cancer: CXCL12 binds to CXCR4 and CXCR7 to promote cancer progression and promotes chemoresistance invasion and migration by activating a number of intracellular signaling molecules, including Akt, EGFR, mTOR, NF-κB, and Src [29, 30].